In Vitro Lung Model Market Share, Size,Growth Global Growth Prospects, Trends, Industry Analysis, Key Players and Forecast to 2023

In Vitro Lung Model Market Overview:

The lung in Vitro Models Market is expected to reach USD 427.4 Million by 2023 from an estimated USD 190.5 Million in 2018, at a CAGR of 17.5%. Factors such as growing focus on developing alternatives for animal testing models, technological advancements, and the development of new 3D in vitro models are expected to drive market growth.

The global lung in vitro models market is projected to reach USD 427.4 Million by 2023 from USD 190.5 Million in 2018 at a CAGR of 17.5%. This market is fragmented in nature with a large number of regional and national players. In 2017, Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland) were the top players in the lung in vitro models market and accounted for more than ~80% of the overall market share.

ATCC is an established provider of cell lines and primary cells in the global market. ATCC develops high-quality products, standards, and services to support scientific research and breakthroughs. It has a strong market presence due to its broad portfolio of lung cell lines and primary cell models of normal and diseased lungs. ATCC has a direct sales force in the US and maintains a global network of authorized distributors and partners to reach the scientific community in more than 150 countries. Given its strong portfolio of lung cell lines and primary cells, the company holds the leading position in the global lung in vitro models market.

Request For Sample: 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=78042820  

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the in vitro lung model market and estimate the size of other dependent submarkets. Various secondary sources such as the American Lung Association, National Center for Biotechnology Information, National Centre for Advancing Translational Sciences, European Union Reference Laboratory for alternatives to animal testing (EURL-ECVAM), European Lung Foundation, Annual Reports, Presentations, Press Releases, Journals, Paid Databases, have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.

Download PDF Brochure: 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78042820 

Segmentation:

Lung In Vitro Models Market, By Type

2D Models

3D Models

In-house 3D Models

Commercialized 3D Models

Lung In Vitro Models Market, By Application

Applications of 2D Models

Drug Discovery and Toxicology

3D Model Development

Basic Research

Applications of 3D Models

Drug Discovery and Toxicology

Physiological Research

Stem Cell Research and Regenerative Medicine

Fore More Detail: 

https://www.marketsandmarkets.com/Market-Reports/lung-in-vitro-model-market-78042820.html 

Key Players:

The major players in the Lung in vitro models market include Epithelix (Switzerland), MatTek Corporation (US), Lonza (Switzerland), ATCC (US), InSphero (Switzerland), Emulate (US), AlveoliX (Switzerland), Oncotheis (Switzerland), Insphero (Switzerland), TissUse (Switzerland), Mimetas (Netherlands), and CN Bio Innovations (UK).

Mr. Rohan

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com